| Period Ending | Mar 30, 2013 | Dec 30, 2012 | Sep 29, 2012 | Jun 29, 2012 |
|---|
|
Total Revenue
|
68,205
|
66,298
|
63,846
|
62,072
| | Cost of Revenue | 19,908 | 18,792 | 18,722 | 18,434 | | |
Gross Profit
|
48,297
|
47,506
|
45,124
|
43,638
| |
|
Operating Expenses |
|
Research Development | 10,268 | 9,736 | 9,776 | 9,804 |
|
Selling General and Administrative | 40,696 | 36,023 | 32,114 | 34,389 |
|
Non Recurring |
-
| (6,058) | (5,297) | (149) |
|
Others |
-
|
-
|
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | | |
Operating Income or Loss
|
(2,667)
|
7,805
|
8,531
|
(406)
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | (29) |
-
|
-
| 62 |
|
Earnings Before Interest And Taxes | (2,696) | 7,835 | 8,599 | (344) |
|
Interest Expense |
-
|
-
|
-
|
-
|
|
Income Before Tax | (2,696) | 7,835 | 8,599 | (344) |
|
Income Tax Expense | (2,182) | 1,456 | 1,978 | 118 |
|
Minority Interest |
-
|
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | (514) | 6,379 | 6,621 | (462) | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
(514)
|
6,379
|
6,621
|
(462)
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
(514)
|
6,379
|
6,621
|
(462)
|
|
0.21(1.43%) 12:52PM EDT - Nasdaq Real Time Price